Journal
STEM CELL RESEARCH
Volume 53, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.scr.2021.102279
Keywords
-
Funding
- National Institutes of Health (NIH) [75N92020D00019, R01 HL126527, P01 HL141084]
Ask authors/readers for more resources
This study successfully generated two human iPSC lines from a patient with HCM and his daughter carrying a pathogenic non-coding mutation, providing a valuable resource for studying the molecular basis of HCM and drug screening for HCM. The lines exhibit typical pluripotent cell morphology, high expression of pluripotency markers, normal karyotype, and the ability to differentiate into all three germ layers in vitro.
Hypertrophic cardiomyopathy (HCM) is an inherited heart disease that can cause sudden cardiac death and heart failure. HCM often arises from mutations in sarcomeric genes, among which the MYBPC3 is the most frequently mutated. Here we generated two human induced pluripotent stem cell (iPSC) lines from a HCM patient who has a familial history of HCM and his daughter who carries the pathogenic non-coding mutation. All lines show the typical morphology of pluripotent cells, a high expression of pluripotency markers, normal karyotype, and in vitro capacity to differentiate into all three germ layers. These lines provide a valuable resource for studying the molecular basis of HCM and drug screening for HCM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available